Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?Zacks Investment Research • 07/28/25
Moderna (MRNA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 07/25/25
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1Accesswire • 07/25/25
Moderna (MRNA) Stock Slides as Market Rises: Facts to Know Before You TradeZacks Investment Research • 07/24/25
Kohl's Looks Like a Meme Stock Now. Rivian, Birkenstock, and Others That Could Follow.Barrons • 07/22/25
How IBM and Moderna's partnership could lead to an explosion in drug developmentFast Company • 07/19/25
MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric PatientsZacks Investment Research • 07/11/25
Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025Accesswire • 07/11/25
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 MonthsBenzinga • 07/10/25
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 DiseaseAccesswire • 07/10/25
Moderna stock rallies on HHS lawsuit news: analyst says negative sentiment reversingInvezz • 07/08/25